Low Dose Naltrexone & Autoimmune Conditions

There is growing recognition in the scientific community that autoimmune diseases result from immunodeficiency, which disturbs the ability of the immune system to distinguish "self" from "non-self". The normalization of the immune system induced by LDN makes it an obvious candidate for a treatment plan in such diseases.The experience of people who have autoimmune diseases and who have begun LDN treatment has been remarkable. 

  • Immunosuppressive Drugs
  • Ulcerative colitis

Related Conference of Low Dose Naltrexone & Autoimmune Conditions

April 04-05, 2024

38th International Conference on Immunology

Madrid, Spain
May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland

Low Dose Naltrexone & Autoimmune Conditions Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in